HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Francesco Ricciuti Selected Research

Induction Chemotherapy

7/2005Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Francesco Ricciuti Research Topics

Disease

1Lymphomatoid Papulosis
03/2013
1Pyoderma Gangrenosum
03/2006
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
07/2005
1Acute Promyelocytic Leukemia
11/2002
1Pathologic Complete Response
11/2002

Drug/Important Bio-Agent (IBA)

1SteroidsIBA
03/2013
1Tacrolimus (Prograf)FDA LinkGeneric
03/2006
1LenograstimIBA
07/2005
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
07/2005
1Tretinoin (Retinoic Acid)FDA LinkGeneric
11/2002
1Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric
11/2002
1Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
11/2002
1Cytarabine (Cytosar-U)FDA LinkGeneric
11/2002
1Methotrexate (Mexate)FDA LinkGeneric
11/2002

Therapy/Procedure

1PUVA Therapy
03/2013
1Induction Chemotherapy
07/2005
1Drug Therapy (Chemotherapy)
11/2002
1Intramuscular Injections
11/2002
1Therapeutics
11/2002